Caterina Marchiò
Caterina Marchiò
Dirección de correo verificada de
TítuloCitado porAño
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
N Turner, A Pearson, R Sharpe, M Lambros, F Geyer, MA Lopez-Garcia, ...
Cancer research 70 (5), 2085-2094, 2010
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
DSP Tan, C Marchió, RL Jones, K Savage, IE Smith, M Dowsett, ...
Breast cancer research and treatment 111 (1), 27-44, 2008
Breast cancer precursors revisited: molecular features and progression pathways
MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki, C Marchió, JS Reis‐Filho
Histopathology 57 (2), 171-192, 2010
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis
C Marchio, MB Lambros, P Gugliotta, LV Di Cantogno, C Botta, B Pasini, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
Tiling path genomic profiling of grade 3 invasive ductal breast cancers
R Natrajan, MB Lambros, SM Rodríguez-Pinilla, G Moreno-Bueno, ...
Clinical cancer research 15 (8), 2711-2722, 2009
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
E Arriola, C Marchio, DSP Tan, SC Drury, MB Lambros, R Natrajan, ...
Laboratory investigation 88 (5), 491, 2008
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas
DSP Tan, MBK Lambros, S Rayter, R Natrajan, R Vatcheva, Q Gao, ...
Clinical cancer research 15 (7), 2269-2280, 2009
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
C Marchio, M Iravani, R Natrajan, MB Lambros, K Savage, N Tamber, ...
The Journal of pathology 215 (4), 398-410, 2008
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal …
L Hernandez, PM Wilkerson, MB Lambros, A Campion‐Flora, ...
The Journal of pathology 227 (1), 42-52, 2012
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166, 2014
Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’of exocrine gland carcinomas)
C Marchio, B Weigelt, JS Reis-Filho
Journal of clinical pathology 63 (3), 220-228, 2010
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
MA Thorat, C Marchio, A Morimiya, K Savage, H Nakshatri, JS Reis-Filho, ...
Journal of clinical pathology 61 (3), 327-332, 2008
SF3B1 mutations constitute a novel therapeutic target in breast cancer
SL Maguire, A Leonidou, P Wai, C Marchiò, CKY Ng, A Sapino, ...
The Journal of pathology 235 (4), 571-580, 2015
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems
L Righi, A Sapino, C Marchiò, M Papotti, G Bussolati
Seminars in diagnostic pathology 27 (1), 69-76, 2010
ESR1 gene amplification in breast cancer: a common phenomenon?
JS Reis-Filho, S Drury, MB Lambros, C Marchio, N Johnson, R Natrajan, ...
Nature genetics 40 (7), 809, 2008
The role of molecular analysis in breast cancer
FC Geyer, C Marchiò, JS Reis-Filho
Pathology 41 (1), 77-88, 2009
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
R Natrajan, MBK Lambros, FC Geyer, C Marchio, DSP Tan, R Vatcheva, ...
Genes, Chromosomes and Cancer 48 (4), 351-365, 2009
Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure
A Sapino, C Marchiò, R Senetta, I Castellano, L Macrì, P Cassoni, ...
Virchows Archiv 449 (3), 288-296, 2006
The genomic profile of HER2‐amplified breast cancers: the influence of ER status
C Marchio, R Natrajan, KK Shiu, MBK Lambros, SM Rodriguez‐Pinilla, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?
LA Brown, J Hoog, SF Chin, Y Tao, AA Zayed, K Chin, AE Teschendorff, ...
Nature genetics 40 (7), 806, 2008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20